Search alternatives:
fold decrease » fold increase (Expand Search), fold increased (Expand Search)
we decrease » _ decrease (Expand Search), mean decrease (Expand Search), teer decrease (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a we » a web (Expand Search), a e (Expand Search), a de (Expand Search)
Showing 821 - 840 results of 151,239 for search '(( a we decrease ) OR ( 5 ((fold decrease) OR (((nn decrease) OR (a decrease)))) ))', query time: 1.79s Refine Results
  1. 821
    Image4_Vaccine induced mucosal and systemic memory NK/ILCs elicit decreased risk of SIV/SHIV acquisition.jpeg

    Image4_Vaccine induced mucosal and systemic memory NK/ILCs elicit decreased risk of SIV/SHIV acquisition.jpeg by Mohammad Arif Rahman (8267352)

    Published 2024
    “…<p>SIV and HIV-based envelope V1-deleted (ΔV1) vaccines, delivered systemically by the DNA/ALVAC/gp120 platform, decrease the risk of mucosal SIV or SHIV acquisition more effectively than V1-replete vaccines. …”
    Save to List
    Saved in:
  2. 822
    Image2_Vaccine induced mucosal and systemic memory NK/ILCs elicit decreased risk of SIV/SHIV acquisition.jpeg

    Image2_Vaccine induced mucosal and systemic memory NK/ILCs elicit decreased risk of SIV/SHIV acquisition.jpeg by Mohammad Arif Rahman (8267352)

    Published 2024
    “…<p>SIV and HIV-based envelope V1-deleted (ΔV1) vaccines, delivered systemically by the DNA/ALVAC/gp120 platform, decrease the risk of mucosal SIV or SHIV acquisition more effectively than V1-replete vaccines. …”
    Save to List
    Saved in:
  3. 823
    Image6_Vaccine induced mucosal and systemic memory NK/ILCs elicit decreased risk of SIV/SHIV acquisition.jpeg

    Image6_Vaccine induced mucosal and systemic memory NK/ILCs elicit decreased risk of SIV/SHIV acquisition.jpeg by Mohammad Arif Rahman (8267352)

    Published 2024
    “…<p>SIV and HIV-based envelope V1-deleted (ΔV1) vaccines, delivered systemically by the DNA/ALVAC/gp120 platform, decrease the risk of mucosal SIV or SHIV acquisition more effectively than V1-replete vaccines. …”
    Save to List
    Saved in:
  4. 824
    Image1_Vaccine induced mucosal and systemic memory NK/ILCs elicit decreased risk of SIV/SHIV acquisition.jpeg

    Image1_Vaccine induced mucosal and systemic memory NK/ILCs elicit decreased risk of SIV/SHIV acquisition.jpeg by Mohammad Arif Rahman (8267352)

    Published 2024
    “…<p>SIV and HIV-based envelope V1-deleted (ΔV1) vaccines, delivered systemically by the DNA/ALVAC/gp120 platform, decrease the risk of mucosal SIV or SHIV acquisition more effectively than V1-replete vaccines. …”
    Save to List
    Saved in:
  5. 825
    Image3_Vaccine induced mucosal and systemic memory NK/ILCs elicit decreased risk of SIV/SHIV acquisition.jpeg

    Image3_Vaccine induced mucosal and systemic memory NK/ILCs elicit decreased risk of SIV/SHIV acquisition.jpeg by Mohammad Arif Rahman (8267352)

    Published 2024
    “…<p>SIV and HIV-based envelope V1-deleted (ΔV1) vaccines, delivered systemically by the DNA/ALVAC/gp120 platform, decrease the risk of mucosal SIV or SHIV acquisition more effectively than V1-replete vaccines. …”
    Save to List
    Saved in:
  6. 826
    Image7_Vaccine induced mucosal and systemic memory NK/ILCs elicit decreased risk of SIV/SHIV acquisition.jpeg

    Image7_Vaccine induced mucosal and systemic memory NK/ILCs elicit decreased risk of SIV/SHIV acquisition.jpeg by Mohammad Arif Rahman (8267352)

    Published 2024
    “…<p>SIV and HIV-based envelope V1-deleted (ΔV1) vaccines, delivered systemically by the DNA/ALVAC/gp120 platform, decrease the risk of mucosal SIV or SHIV acquisition more effectively than V1-replete vaccines. …”
    Save to List
    Saved in:
  7. 827
    Table1_Vaccine induced mucosal and systemic memory NK/ILCs elicit decreased risk of SIV/SHIV acquisition.xlsx

    Table1_Vaccine induced mucosal and systemic memory NK/ILCs elicit decreased risk of SIV/SHIV acquisition.xlsx by Mohammad Arif Rahman (8267352)

    Published 2024
    “…<p>SIV and HIV-based envelope V1-deleted (ΔV1) vaccines, delivered systemically by the DNA/ALVAC/gp120 platform, decrease the risk of mucosal SIV or SHIV acquisition more effectively than V1-replete vaccines. …”
    Save to List
    Saved in:
  8. 828
    MMP-2 production is decreased following ALK5 inhibition.

    MMP-2 production is decreased following ALK5 inhibition. by Rebecca A. Scott (488956)

    Published 2020
    Save to List
    Saved in:
  9. 829
    Example of fold increases and decreases in expression between developmental stages (blue, based on (<i>X</i><sub><i>t+1</i></sub><i>-X</i><sub><i>t</i></sub>) / <i>min</i> [<i>X</i><sub><i>t</i></sub>, <i>X</i><sub><i>t+1</i></sub>], where <i>X</i> is the expression level and <i>t</i> is the stage), the continuous ancestral state estimations of the fold increases and decreases between stages for nodes of interest (also blue), the corresponding estimates of stage-to-stage relative expression across stages normalized to the stage of lowest expression (red), and the raw (un-normalized) sequencing counts (black, in parentheses).

    Example of fold increases and decreases in expression between developmental stages (blue, based on (<i>X</i><sub><i>t+1</i></sub><i>-X</i><sub><i>t</i></sub>) / <i>min</i> [<i>X</i... by Frances Trail (647410)

    Published 2017
    Save to List
    Saved in:
  10. 830
    Kolmogorov-Smirnov (KS) test for the different parameter value pairs at a 95% confidence level. We tested the null hypothesis for all parameters: The RMSEs obtained for one pair of parameter values have the same distribution as those obtained for another pair of parameter values.

    Kolmogorov-Smirnov (KS) test for the different parameter value pairs at a 95% confidence level. We tested the null hypothesis for all parameters: The RMSEs obtained for one pair of... by Cyrine Chenaoui (22177098)

    Published 2025
    Save to List
    Saved in:
  11. 831
    Image1_Reduction of kinesin I heavy chain decreases tau hyperphosphorylation, aggregation, and memory impairment in Alzheimer’s disease and tauopathy models.jpg

    Image1_Reduction of kinesin I heavy chain decreases tau hyperphosphorylation, aggregation, and memory impairment in Alzheimer’s disease and tauopathy models.jpg by Karthikeyan Selvarasu (14004867)

    Published 2022
    “…We also found that the knockdown and knockout (KO) of KIFf5B significantly decreased the tau stability, and overexpression of KIF5B in KIF5B-KO cells significantly increased the expression of phosphorylated and total tau levels. …”
    Save to List
    Saved in:
  12. 832
    Table_1_When and Why Did Human Brains Decrease in Size? A New Change-Point Analysis and Insights From Brain Evolution in Ants.XLSX

    Table_1_When and Why Did Human Brains Decrease in Size? A New Change-Point Analysis and Insights From Brain Evolution in Ants.XLSX by Jeremy M. DeSilva (7247009)

    Published 2021
    “…<p>Human brain size nearly quadrupled in the six million years since Homo last shared a common ancestor with chimpanzees, but human brains are thought to have decreased in volume since the end of the last Ice Age. …”
    Save to List
    Saved in:
  13. 833
    5-year risk of cardiovascular diseases under exposure deciles of A) HbA1C-CV and B) FPG-CV.

    5-year risk of cardiovascular diseases under exposure deciles of A) HbA1C-CV and B) FPG-CV. by Khadije Maajani (10125692)

    Published 2025
    Save to List
    Saved in:
  14. 834
    The steps we follow to train and validate a predictive model for categorizing an evaluator’s opinion toward a contributor’s pull request as likely to increase, decrease, or not affect trust.

    The steps we follow to train and validate a predictive model for categorizing an evaluator’s opinion toward a contributor’s pull request as likely to increase, decrease, or not affect trust. by Hitesh Sapkota (8201127)

    Published 2019
    Save to List
    Saved in:
  15. 835
    Computational analysis of pediatric ventricular assist device implantation to decrease cerebral particulate embolization

    Computational analysis of pediatric ventricular assist device implantation to decrease cerebral particulate embolization by ThuyTien Nguyen (775693)

    Published 2015
    Save to List
    Saved in:
  16. 836
    Anti-EBOV GP IgGs Lacking α1-3-Galactose and Neu5Gc Prolong Survival and Decrease Blood Viral Load in EBOV-Infected Guinea Pigs

    Anti-EBOV GP IgGs Lacking α1-3-Galactose and Neu5Gc Prolong Survival and Decrease Blood Viral Load in EBOV-Infected Guinea Pigs by Olivier Reynard (354756)

    Published 2016
    “…In this paper, we explored whether low immunogenicity IgGs had a protective effect on a guinea pig model of Ebola virus (EBOV) infection. …”
    Save to List
    Saved in:
  17. 837
    S1 Data -

    S1 Data - by Jordan A. Gunning (18143970)

    Published 2024
    “…Specifically, total immune cells (CD45+) decrease at days 2 and 5 following IR, macrophages (F4/80+CD11b+) decrease at day 2 and 5 and increase at day 30, while neutrophils (Ly6G+CD11b+) significantly increase at day 30 following IR. …”
    Save to List
    Saved in:
  18. 838
    Discovery of the Triazolo[1,5‑<i>a</i>]Pyrimidine-Based Derivative WS-898 as a Highly Efficacious and Orally Bioavailable ABCB1 Inhibitor Capable of Overcoming Multidrug Resistance

    Discovery of the Triazolo[1,5‑<i>a</i>]Pyrimidine-Based Derivative WS-898 as a Highly Efficacious and Orally Bioavailable ABCB1 Inhibitor Capable of Overcoming Multidrug Resistance... by Shuai Wang (109515)

    Published 2021
    “…Here, we reported our medicinal chemistry efforts that led to the discovery of the triazolo­[1,5-<i>a</i>]­pyrimidine derivative <b>WS-898</b> as a highly effective ABCB1 inhibitor capable of reversing paclitaxel (PTX) resistance in drug-resistant SW620/Ad300, KB-C2, and HEK293/ABCB1 cells (IC<sub>50</sub> = 5.0, 3.67, and 3.68 nM, respectively), more potent than verapamil and zosuquidar. …”
    Save to List
    Saved in:
  19. 839
    Discovery of the Triazolo[1,5‑<i>a</i>]Pyrimidine-Based Derivative WS-898 as a Highly Efficacious and Orally Bioavailable ABCB1 Inhibitor Capable of Overcoming Multidrug Resistance

    Discovery of the Triazolo[1,5‑<i>a</i>]Pyrimidine-Based Derivative WS-898 as a Highly Efficacious and Orally Bioavailable ABCB1 Inhibitor Capable of Overcoming Multidrug Resistance... by Shuai Wang (109515)

    Published 2021
    “…Here, we reported our medicinal chemistry efforts that led to the discovery of the triazolo­[1,5-<i>a</i>]­pyrimidine derivative <b>WS-898</b> as a highly effective ABCB1 inhibitor capable of reversing paclitaxel (PTX) resistance in drug-resistant SW620/Ad300, KB-C2, and HEK293/ABCB1 cells (IC<sub>50</sub> = 5.0, 3.67, and 3.68 nM, respectively), more potent than verapamil and zosuquidar. …”
    Save to List
    Saved in:
  20. 840
    Enalaprilat and losartan decrease erythroid precursors frequency in cells from patients with polycythemia vera

    Enalaprilat and losartan decrease erythroid precursors frequency in cells from patients with polycythemia vera by Angela Bozza (8908091)

    Published 2023
    “…After the discovery of a mutation in the Janus kinase 2 (<i>JAK</i>2<sup>V617F</sup>), JAK2 inhibitors have been tested as second-line therapies. …”
    Save to List
    Saved in:

Search Tools: